Dexco S.A. Logo

Dexco S.A.

DXCO3.SA

(2.0)
Stock Price

8,08 BRL

5.19% ROA

12.74% ROE

7.97x PER

Market Cap.

6.465.135.656,00 BRL

103.79% DER

2.69% Yield

10.69% NPM

Dexco S.A. Stock Analysis

Dexco S.A. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Dexco S.A. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.97x) suggests it's undervalued, making it an attractive opportunity for investors.

2 Assets Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

3 ROE

The stock's ROE falls within an average range (11.25%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (4.37%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

6 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (133), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

7 DER

The company has a high debt to equity ratio (109%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

8 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

Dexco S.A. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Dexco S.A. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Dexco S.A. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Dexco S.A. Revenue
Year Revenue Growth
2005 306.506.000
2006 340.376.000 9.95%
2007 418.980.000 18.76%
2008 520.173.000 19.45%
2009 1.437.796.000 63.82%
2010 2.741.810.000 47.56%
2011 3.124.374.000 12.24%
2012 3.394.399.000 7.96%
2013 3.872.705.000 12.35%
2014 3.984.507.000 2.81%
2015 3.963.214.000 -0.54%
2016 3.909.760.000 -1.37%
2017 3.990.866.000 2.03%
2018 4.949.361.000 19.37%
2019 5.011.706.000 1.24%
2020 5.879.616.000 14.76%
2021 8.170.241.000 28.04%
2022 8.486.650.000 3.73%
2023 7.075.812.000 -19.94%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Dexco S.A. Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Dexco S.A. General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 16.942.000
2006 14.758.000 -14.8%
2007 18.206.000 18.94%
2008 25.315.000 28.08%
2009 96.172.000 73.68%
2010 119.445.000 19.48%
2011 120.344.000 0.75%
2012 110.535.000 -8.87%
2013 127.898.000 13.58%
2014 136.034.000 5.98%
2015 154.632.000 12.03%
2016 141.552.000 -9.24%
2017 143.308.000 1.23%
2018 180.736.000 20.71%
2019 215.162.000 16%
2020 237.878.000 9.55%
2021 121.522.000 -95.75%
2022 151.629.000 19.86%
2023 402.196.000 62.3%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Dexco S.A. EBITDA
Year EBITDA Growth
2005 87.696.000
2006 47.252.000 -85.59%
2007 135.648.000 65.17%
2008 211.586.000 35.89%
2009 274.293.000 22.86%
2010 1.140.107.000 75.94%
2011 1.104.785.000 -3.2%
2012 1.165.677.000 5.22%
2013 1.441.554.000 19.14%
2014 1.063.796.000 -35.51%
2015 539.852.000 -97.05%
2016 1.043.120.000 48.25%
2017 942.141.000 -10.72%
2018 725.677.000 -29.83%
2019 887.508.000 18.23%
2020 1.217.135.000 27.08%
2021 2.772.158.000 56.09%
2022 1.767.527.000 -56.84%
2023 3.148.180.000 43.86%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Dexco S.A. Gross Profit
Year Gross Profit Growth
2005 104.337.000
2006 96.015.000 -8.67%
2007 154.087.000 37.69%
2008 200.635.000 23.2%
2009 483.376.000 58.49%
2010 933.695.000 48.23%
2011 1.011.931.000 7.73%
2012 1.183.141.000 14.47%
2013 1.443.667.000 18.05%
2014 1.217.189.000 -18.61%
2015 1.099.801.000 -10.67%
2016 1.009.132.000 -8.98%
2017 1.143.769.000 11.77%
2018 1.298.513.000 11.92%
2019 1.294.144.000 -0.34%
2020 1.851.820.000 30.12%
2021 2.869.848.000 35.47%
2022 2.871.787.000 0.07%
2023 2.116.880.000 -35.66%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Dexco S.A. Net Profit
Year Net Profit Growth
2005 23.322.000
2006 -2.215.000 1152.91%
2007 45.922.000 104.82%
2008 75.095.000 38.85%
2009 97.935.000 23.32%
2010 467.247.000 79.04%
2011 374.860.000 -24.65%
2012 459.256.000 18.38%
2013 519.920.000 11.67%
2014 390.349.000 -33.19%
2015 183.497.000 -112.73%
2016 23.646.000 -676.02%
2017 184.875.000 87.21%
2018 431.573.000 57.16%
2019 405.564.000 -6.41%
2020 453.812.000 10.63%
2021 1.725.407.000 73.7%
2022 755.861.000 -128.27%
2023 1.189.504.000 36.46%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Dexco S.A. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 1 0%
2011 0 0%
2012 1 0%
2013 1 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 1 0%
2019 0 0%
2020 1 0%
2021 2 100%
2022 1 0%
2023 1 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Dexco S.A. Free Cashflow
Year Free Cashflow Growth
2005 12.479.000
2006 847.000 -1373.32%
2007 -54.333.000 101.56%
2008 -230.620.000 76.44%
2009 -183.263.000 -25.84%
2010 357.299.000 151.29%
2011 778.583.000 54.11%
2012 -59.553.000 1407.38%
2013 200.764.000 129.66%
2014 218.398.000 8.07%
2015 105.539.000 -106.94%
2016 69.763.000 -51.28%
2017 38.786.000 -79.87%
2018 -59.203.000 165.51%
2019 652.803.000 109.07%
2020 1.020.322.000 36.02%
2021 851.116.000 -19.88%
2022 -419.410.000 302.93%
2023 25.020.000 1776.3%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Dexco S.A. Operating Cashflow
Year Operating Cashflow Growth
2005 55.705.000
2006 60.640.000 8.14%
2007 116.872.000 48.11%
2008 106.195.000 -10.05%
2009 89.113.000 -19.17%
2010 816.863.000 89.09%
2011 778.583.000 -4.92%
2012 772.661.000 -0.77%
2013 768.385.000 -0.56%
2014 678.043.000 -13.32%
2015 574.484.000 -18.03%
2016 450.598.000 -27.49%
2017 404.698.000 -11.34%
2018 382.872.000 -5.7%
2019 1.108.492.000 65.46%
2020 1.507.730.000 26.48%
2021 1.708.383.000 11.75%
2022 793.690.000 -115.25%
2023 365.690.000 -117.04%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Dexco S.A. Capital Expenditure
Year Capital Expenditure Growth
2005 43.226.000
2006 59.793.000 27.71%
2007 171.205.000 65.08%
2008 336.815.000 49.17%
2009 272.376.000 -23.66%
2010 459.564.000 40.73%
2011 0 0%
2012 832.214.000 100%
2013 567.621.000 -46.61%
2014 459.645.000 -23.49%
2015 468.945.000 1.98%
2016 380.835.000 -23.14%
2017 365.912.000 -4.08%
2018 442.075.000 17.23%
2019 455.689.000 2.99%
2020 487.408.000 6.51%
2021 857.267.000 43.14%
2022 1.213.100.000 29.33%
2023 340.670.000 -256.09%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Dexco S.A. Equity
Year Equity Growth
2005 431.630.000
2006 247.488.000 -74.4%
2007 482.900.000 48.75%
2008 515.566.000 6.34%
2009 2.371.934.000 78.26%
2010 3.451.866.000 31.29%
2011 3.689.209.000 6.43%
2012 4.019.981.000 8.23%
2013 4.365.005.000 7.9%
2014 4.543.099.000 3.92%
2015 4.532.481.000 -0.23%
2016 4.569.507.000 0.81%
2017 4.715.365.000 3.09%
2018 4.634.867.000 -1.74%
2019 4.932.168.000 6.03%
2020 5.188.364.000 4.94%
2021 5.734.911.000 9.53%
2022 5.961.564.000 3.8%
2023 6.514.124.000 8.48%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Dexco S.A. Assets
Year Assets Growth
2005 829.878.000
2006 627.413.000 -32.27%
2007 934.826.000 32.88%
2008 1.127.531.000 17.09%
2009 4.333.741.000 73.98%
2010 6.170.867.000 29.77%
2011 6.814.150.000 9.44%
2012 7.758.598.000 12.17%
2013 8.178.327.000 5.13%
2014 8.797.107.000 7.03%
2015 9.008.059.000 2.34%
2016 9.340.796.000 3.56%
2017 9.465.574.000 1.32%
2018 9.622.087.000 1.63%
2019 10.714.688.000 10.2%
2020 11.498.520.000 6.82%
2021 13.420.331.000 14.32%
2022 15.624.811.000 14.11%
2023 16.530.053.000 5.48%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Dexco S.A. Liabilities
Year Liabilities Growth
2005 341.337.000
2006 379.925.000 10.16%
2007 451.926.000 15.93%
2008 600.929.000 24.8%
2009 1.961.090.000 69.36%
2010 2.718.339.000 27.86%
2011 3.121.340.000 12.91%
2012 3.734.993.000 16.43%
2013 3.813.322.000 2.05%
2014 4.188.207.000 8.95%
2015 4.391.583.000 4.63%
2016 4.770.144.000 7.94%
2017 4.749.255.000 -0.44%
2018 4.987.220.000 4.77%
2019 5.782.520.000 13.75%
2020 6.310.156.000 8.36%
2021 7.685.420.000 17.89%
2022 9.663.247.000 20.47%
2023 10.015.929.000 3.52%

Dexco S.A. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
9.18
Net Income per Share
1
Price to Earning Ratio
7.97x
Price To Sales Ratio
0.87x
POCF Ratio
6.67
PFCF Ratio
-42.34
Price to Book Ratio
1.01
EV to Sales
1.55
EV Over EBITDA
4.9
EV to Operating CashFlow
11.87
EV to FreeCashFlow
-75.32
Earnings Yield
0.13
FreeCashFlow Yield
-0.02
Market Cap
6,47 Bil.
Enterprise Value
11,50 Bil.
Graham Number
13.39
Graham NetNet
-8.03

Income Statement Metrics

Net Income per Share
1
Income Quality
1.18
ROE
0.13
Return On Assets
0.04
Return On Capital Employed
0.05
Net Income per EBT
1.2
EBT Per Ebit
0.95
Ebit per Revenue
0.09
Effective Tax Rate
-0.09

Margins

Sales, General, & Administrative to Revenue
0.04
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.31
Operating Profit Margin
0.09
Pretax Profit Margin
0.09
Net Profit Margin
0.11

Dividends

Dividend Yield
0.03
Dividend Yield %
2.69
Payout Ratio
0
Dividend Per Share
0.22

Operating Metrics

Operating Cashflow per Share
1.2
Free CashFlow per Share
-0.19
Capex to Operating CashFlow
-1.16
Capex to Revenue
-0.15
Capex to Depreciation
-1.1
Return on Invested Capital
0.06
Return on Tangible Assets
0.05
Days Sales Outstanding
75.08
Days Payables Outstanding
70.08
Days of Inventory on Hand
113.37
Receivables Turnover
4.86
Payables Turnover
5.21
Inventory Turnover
3.22
Capex per Share
-1.39

Balance Sheet

Cash per Share
2,00
Book Value per Share
7,93
Tangible Book Value per Share
6.97
Shareholders Equity per Share
7.93
Interest Debt per Share
8.9
Debt to Equity
1.04
Debt to Assets
0.4
Net Debt to EBITDA
2.15
Current Ratio
1.34
Tangible Asset Value
5,63 Bil.
Net Current Asset Value
-5,27 Bil.
Invested Capital
1.04
Working Capital
1,20 Bil.
Intangibles to Total Assets
0.05
Average Receivables
1,60 Bil.
Average Payables
1,02 Bil.
Average Inventory
1574218500
Debt to Market Cap
1.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Dexco S.A. Dividends
Year Dividends Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2017 0 0%
2018 1 0%
2019 0 0%
2020 0 0%
2021 2 100%
2022 0 0%

Dexco S.A. Profile

About Dexco S.A.

Dexco S.A., together with its subsidiaries, produces and sells wood panels in Brazil and internationally. The company operates through Deca, Wood, and Ceramic Tiles divisions. It offers hardboard, medium density particle (MDP) panels, medium and high-density fiberboard (MDF and HDF) panels, and semi-finished components for furniture, as well as laminate flooring under the Durafloor brand; sanitary ceramic and metal products, and showers under the Deca, Hydra, Belize, Elizabeth, and Hydra Corona brands; and ceramic tiles under the Ceusa, Cecrisa, and Portinari brands. The company was formerly known as Duratex S.A. and changed its name to Dexco S.A. in August 2021. Dexco S.A. was founded in 1951 and is based in São Paulo, Brazil.

CEO
Mr. Antonio Joaquim de Oliveir
Employee
14.228
Address
Paulista Avenue, 1938
São Paulo, 01310-942

Dexco S.A. Executives & BODs

Dexco S.A. Executives & BODs
# Name Age
1 Mr. Carlos Henrique Pinto Haddad
Vice-President of Administration, Finance & Investor Relations
70
2 Mr. Antonio Joaquim de Oliveira
Chief Executive Officer
70
3 Ms. Glizia Maria do Prado
Director of Human Resources
70
4 Natasha Utescher
Investor Relations Manager
70
5 Raul Guimarães Guaragna
Head of Wood Division
70
6 Mr. Marco Antônio Milleo
Deca Industrial Director
70
7 Mr. José Ricardo Paraíso Ferraz
Operations Director of the Wood Division
70
8 Gilmar Menegon
Ceramic Tiles Director
70
9 Marcelo Jose Teixeira Izzo
Executive Vice President & Head of Deca
70
10 Felipe Saraiva
Investor Relations Coordinator
70

Dexco S.A. Competitors

Vibra Energia S.A. Logo
Vibra Energia S.A.

VBBR3.SA

(1.5)
CSN Mineração S.A. Logo
CSN Mineração S.A.

CMIN3.SA

(1.8)
Rede D'Or São Luiz S.A. Logo
Rede D'Or São Luiz S.A.

RDOR3.SA

(2.2)
Sendas Distribuidora S.A. Logo
Sendas Distribuidora S.A.

ASAI3.SA

(2.0)
TIM S.A. Logo
TIM S.A.

TIMS3.SA

(1.8)